Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 5.28
+0.09 (1.73%)
Mar 20, 2026, 5:29 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 256.27 million as of March 20, 2026. Its market cap has increased by 214.76% in one year.
Market Cap
256.27M
Enterprise Value
231.42M
Revenue
10.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.28
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 256.27M, an increase of 108.94%. That is a compound annual growth rate of 16.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 256.27M | 1.15% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | 122.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascelia Pharma AB | 376.80M |
| Bio-Works Technologies AB | 327.11M |
| Lipum AB | 304.40M |
| Intervacc AB | 251.86M |
| Mendus AB | 242.63M |
| Sprint Bioscience AB | 210.50M |
| Initiator Pharma | 204.67M |
| AlzeCure Pharma AB | 197.65M |